Bullish option flow detected in Aurinia Pharmaceuticals with 2,384 calls trading, 1.1x expected, and implied vol increasing almost 8 points to 94.93%. Jan-25 20 calls and Jan-24 8 calls are the most active options, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 0.30. Earnings are expected on February 27th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AUPH:
- Aurinia Pharmaceuticals call volume above normal and directionally bullish
- Aurinia Pharmaceuticals sees FY24 net product revenue $200M-$220M
- Aurinia Pharmaceuticals sees FY23 revenue about $176M, consensus $174.71M
- Aurinia Pharmaceuticals sees Q4 revenue about $45M, consensus $44.2M
- Aurinia Pharmaceuticals submits IND application to FDA for AUR200
